High LDL and triglycerides raise cardiovascular risk. Statins remain the first-line therapy to lower LDL and prevent events. When statins are insufficient or not tolerated, clinicians can add ezetimibe, bile-acid sequestrants, PCSK9 inhibitors, or inclisiran. Niacin is rarely used for prevention today. Lifestyle interventions - dietary soluble fiber, plant sterols, weight loss, exercise, and smoking cessation - complement medicines. Discuss supplements and treatment choices with your clinician.
Overview
Disorders of lipids and lipoproteins are common. High cholesterol can be primary (genetic) or secondary to conditions such as diabetes, hypothyroidism, or certain medications. Elevated LDL cholesterol and triglycerides increase the risk of coronary heart disease and stroke. Treatment combines proven prescription medicines with diet, exercise, and other lifestyle measures.
Prescription medicines - what they do and when they help
Statins (first-line)
Statins lower LDL cholesterol and reduce the risk of heart attack and stroke. Clinicians prescribe them for people with clinical atherosclerotic cardiovascular disease or with high LDL or risk levels. Common side effects include muscle symptoms and, rarely, liver enzyme changes; monitoring and dose adjustments help manage these concerns.Ezetimibe and bile-acid sequestrants
Ezetimibe (a cholesterol absorption inhibitor) lowers LDL and has shown outcome benefit when added to statin therapy in selected patients. Bile-acid sequestrants (cholestyramine, colesevelam) bind cholesterol in the gut and lower LDL; they are options when statins are not tolerated or need support.PCSK9 inhibitors and inclisiran
Monoclonal antibodies that block PCSK9 (evolocumab, alirocumab) and the siRNA therapy inclisiran offer potent LDL lowering and are used for high-risk patients who need additional LDL reduction despite statins. These are typically given by injection and used under specialist guidance.Niacin, fibrates, and prescription omega-3s
Niacin (vitamin B3) lowers triglycerides and can raise HDL but is no longer routinely recommended for cardiovascular prevention because additional outcome benefits are minimal and side effects are common. Fibrates remain useful for very high triglycerides to reduce pancreatitis risk. A prescription omega-3 medication (icosapent ethyl) has been shown to reduce cardiovascular events in selected patients with elevated triglycerides on statin therapy.Natural approaches and lifestyle measures
Diet, weight management, physical activity, and smoking cessation are central to managing cholesterol. Soluble fiber (oats, psyllium), nuts, legumes, fatty fish, and plant sterols/stanols help lower LDL modestly. The Mediterranean-style dietary pattern shows consistent cardiovascular benefit.
Some herbal products and teas (for example, garlic or certain Chinese teas) have limited or mixed evidence for cholesterol lowering. Use supplements cautiously and discuss them with your clinician because of variable potency and potential drug interactions.
Practical approach
Work with your clinician to assess cardiovascular risk, set LDL targets, and choose therapies. For many people, a statin plus lifestyle change is the foundation. Add-on therapies (ezetimibe, PCSK9 inhibitors, inclisiran, fibrates, or prescription omega-3) are options when risk or residual lipid abnormalities justify them.
Combining evidence-based medicines with diet, regular exercise, and smoking cessation gives the best chance to lower cholesterol and reduce cardiovascular events.
FAQs about Cholesterol Medicine
Are statins safe?
Should I take niacin to raise HDL?
Can diet and supplements replace medicines?
Do herbal teas or garlic meaningfully lower cholesterol?
News about Cholesterol Medicine
Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters [Visit Site | Read More]
What impact does salmon have on cholesterol levels? - Medical News Today [Visit Site | Read More]
Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts - The Wall Street Journal [Visit Site | Read More]
Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% - Yahoo Finance [Visit Site | Read More]
4 statin alternatives that lower cholesterol - British Heart Foundation [Visit Site | Read More]
‘This is revolutionary!’: Breakthrough cholesterol treatment can cut levels by 69% after one dose - BBC Science Focus Magazine [Visit Site | Read More]
Editas Medicine to present CRISPR cholesterol research at ESGCT - Investing.com [Visit Site | Read More]